BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 35402082)

  • 1. PKHB1, a thrombospondin-1 peptide mimic, induces anti-tumor effect through immunogenic cell death induction in breast cancer cells.
    Calvillo-Rodríguez KM; Mendoza-Reveles R; Gómez-Morales L; Uscanga-Palomeque AC; Karoyan P; Martínez-Torres AC; Rodríguez-Padilla C
    Oncoimmunology; 2022; 11(1):2054305. PubMed ID: 35402082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PKHB1 Tumor Cell Lysate Induces Antitumor Immune System Stimulation and Tumor Regression in Syngeneic Mice with Tumoral T Lymphoblasts.
    Martínez-Torres AC; Calvillo-Rodríguez KM; Uscanga-Palomeque AC; Gómez-Morales L; Mendoza-Reveles R; Caballero-Hernández D; Karoyan P; Rodríguez-Padilla C
    J Oncol; 2019; 2019():9852361. PubMed ID: 31275386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD47 agonist peptide PKHB1 induces immunogenic cell death in T-cell acute lymphoblastic leukemia cells.
    Uscanga-Palomeque AC; Calvillo-Rodríguez KM; Gómez-Morales L; Lardé E; Denèfle T; Caballero-Hernández D; Merle-Béral H; Susin SA; Karoyan P; Martínez-Torres AC; Rodríguez-Padilla C
    Cancer Sci; 2019 Jan; 110(1):256-268. PubMed ID: 30460757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CDK12/13 inhibition induces immunogenic cell death and enhances anti-PD-1 anticancer activity in breast cancer.
    Li Y; Zhang H; Li Q; Zou P; Huang X; Wu C; Tan L
    Cancer Lett; 2020 Dec; 495():12-21. PubMed ID: 32941949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The bovine dialysable leukocyte extract IMMUNEPOTENT CRP induces immunogenic cell death in breast cancer cells leading to long-term antitumour memory.
    Reyes-Ruiz A; Calvillo-Rodriguez KM; Martínez-Torres AC; Rodríguez-Padilla C
    Br J Cancer; 2021 Apr; 124(8):1398-1410. PubMed ID: 33531687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conventional amphotericin B elicits markers of immunogenic cell death on leukemic blasts, mediates immunostimulatory effects on phagocytic cells, and synergizes with PD-L1 blockade.
    Kofla G; Radecke C; Frentsch M; Walther W; Stintzing S; Riess H; Bullinger L; Na IK
    Oncoimmunology; 2022; 11(1):2068109. PubMed ID: 35496500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineered exosomes as an in situ DC-primed vaccine to boost antitumor immunity in breast cancer.
    Huang L; Rong Y; Tang X; Yi K; Qi P; Hou J; Liu W; He Y; Gao X; Yuan C; Wang F
    Mol Cancer; 2022 Feb; 21(1):45. PubMed ID: 35148751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The anticancer peptide RT53 induces immunogenic cell death.
    Pasquereau-Kotula E; Habault J; Kroemer G; Poyet JL
    PLoS One; 2018; 13(8):e0201220. PubMed ID: 30080874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting chronic lymphocytic leukemia with N-methylated thrombospondin-1-derived peptides overcomes drug resistance.
    Pramil E; Herbi Bastian L; Denèfle T; Nemati F; Xiao M; Lardé E; Maloum K; Roos-Weil D; Chapiro E; Le Garff-Tavernier M; Davi F; Decaudin D; Sarfati M; Nguyen-Khac F; Merle-Béral H; Karoyan P; Susin SA
    Blood Adv; 2019 Oct; 3(20):2920-2933. PubMed ID: 31648314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regorafenib induces damage-associated molecular patterns, cancer cell death and immune modulatory effects in a murine triple negative breast cancer model.
    Tseng LM; Lau KY; Chen JL; Chu PY; Huang TT; Lee CH; Wang WL; Chang YY; Huang CT; Huang CC; Chao TC; Tsai YF; Lai JI; Dai MS; Liu CY
    Exp Cell Res; 2023 Aug; 429(1):113652. PubMed ID: 37209991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oleandrin, a cardiac glycoside, induces immunogenic cell death via the PERK/elF2α/ATF4/CHOP pathway in breast cancer.
    Li X; Zheng J; Chen S; Meng FD; Ning J; Sun SL
    Cell Death Dis; 2021 Mar; 12(4):314. PubMed ID: 33762577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxaliplatin and Checkpoint Inhibitor Induces Immunogenic Cells Death and Promotes Therapeutic Efficacy in the Model of Murine Triple Positive Breast Cancer.
    Shi H
    Stud Health Technol Inform; 2023 Nov; 308():329-340. PubMed ID: 38007757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell death induced by cytotoxic CD8
    Jaime-Sanchez P; Uranga-Murillo I; Aguilo N; Khouili SC; Arias MA; Sancho D; Pardo J
    J Immunother Cancer; 2020 Apr; 8(1):. PubMed ID: 32241808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imiquimod Exerts Antitumor Effects by Inducing Immunogenic Cell Death and Is Enhanced by the Glycolytic Inhibitor 2-Deoxyglucose.
    Huang SW; Wang ST; Chang SH; Chuang KC; Wang HY; Kao JK; Liang SM; Wu CY; Kao SH; Chen YJ; Shieh JJ
    J Invest Dermatol; 2020 Sep; 140(9):1771-1783.e6. PubMed ID: 32035924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of immunogenic cell death in radiation-resistant breast cancer stem cells by repurposing anti-alcoholism drug disulfiram.
    Sun T; Yang W; Toprani SM; Guo W; He L; DeLeo AB; Ferrone S; Zhang G; Wang E; Lin Z; Hu P; Wang X
    Cell Commun Signal; 2020 Mar; 18(1):36. PubMed ID: 32138738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence of immunogenic cancer cell death induced by honey-processed Astragalus polysaccharides in vitro and in vivo.
    Sha X; Xu X; Liao S; Chen H; Rui W
    Exp Cell Res; 2022 Jan; 410(1):112948. PubMed ID: 34826423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase-Transformation Nanoparticle-Mediated Sonodynamic Therapy: An Effective Modality to Enhance Anti-Tumor Immune Response by Inducing Immunogenic Cell Death in Breast Cancer.
    Si Y; Yue J; Liu Z; Li M; Du F; Wang X; Dai Z; Hu N; Ju J; Gao S; Wang X; Yuan P
    Int J Nanomedicine; 2021; 16():1913-1926. PubMed ID: 33707946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternol triggers immunogenic cell death
    Li C; Zhang Y; Yan S; Zhang G; Wei W; Qi Z; Li B
    Oncoimmunology; 2021; 10(1):1952539. PubMed ID: 34350063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PTPRC promoted CD8+ T cell mediated tumor immunity and drug sensitivity in breast cancer: based on pan-cancer analysis and artificial intelligence modeling of immunogenic cell death-based drug sensitivity stratification.
    Li P; Wang W; Wang S; Cao G; Pan T; Huang Y; Wan H; Zhang W; Huang Y; Jin H; Wang Z
    Front Immunol; 2023; 14():1145481. PubMed ID: 37388747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tipping the immunostimulatory and inhibitory DAMP balance to harness immunogenic cell death.
    Hayashi K; Nikolos F; Lee YC; Jain A; Tsouko E; Gao H; Kasabyan A; Leung HE; Osipov A; Jung SY; Kurtova AV; Chan KS
    Nat Commun; 2020 Dec; 11(1):6299. PubMed ID: 33288764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.